Syros Pharmaceuticals Inc

General ticker "SYRS" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $9.4M

Syros Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -40.5%.

Estimated limits based on current volatility of 0.1%: low 0.20$, high 0.21$

Factors to consider:

  • Current price 94.9% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [3.97$, 11.05$]
  • 2024-12-30 to 2025-12-30 estimated range: [3.63$, 9.83$]

Financial Metrics affecting the SYRS estimates:

  • Negative: Non-GAAP EPS, $ of -5.68 <= 0.10
  • Negative: Operating profit margin, % of -92.85 <= 1.03
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -47.59 <= 2.35
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85

Similar symbols

Short-term SYRS quotes

Long-term SYRS plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $23.49MM $14.88MM $9.94MM
Operating Expenses $122.91MM $150.75MM $138.92MM
Operating Income $-99.42MM $-135.87MM $-128.99MM
Non-Operating Income $12.86MM $41.22MM $-35.59MM
Interest Expense $3.91MM $4.13MM $5.13MM
R&D Expense $99.87MM $111.94MM $108.15MM
Income(Loss) $-86.56MM $-94.65MM $-164.57MM
Profit(Loss) $-86.56MM $-94.65MM $-164.57MM
Stockholders Equity $85.22MM $127.74MM $16.66MM
Inventory $0.00MM $0.00MM $0.00MM
Assets $182.94MM $244.49MM $168.17MM
Operating Cash Flow $-99.54MM $-123.06MM $-109.71MM
Capital expenditure $1.25MM $1.24MM $0.27MM
Investing Cash Flow $-52.65MM $67.19MM $37.34MM
Financing Cash Flow $70.51MM $131.04MM $43.46MM
Earnings Per Share* $-14.47 $-3.90 $-5.81

* EPS are Split Adjusted, recent splits may be reflected with a delay.